JMP Securities Starts Epizyme (EPZM) at Market Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Dell shares surge on record AI server bookings
- 'No panic anywhere' may be the problem, BofA strategists warn
- Kroger cuts same-store sales outlook, keeps earnings guidance
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Wedbush Starts Epizyme (EPZM) at Outperform
June 26, 2013 4:49 PM EDTWedbush initiated coverage on Epizyme (NASDAQ: EPZM) with an Outperform rating and a price target of $37.00.
"Advances in genetically defining sub-sets of cancer patients have identified members of the family of histone methyltransferase (HMT) proteins as key drivers of malignancy. . .... More
Cowen Starts Epizyme (EPZM) at Outperform
June 25, 2013 10:32 AM EDTCowen initiates coverage on Epizyme (NASDAQ: EPZM) with a Outperform.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
Leerink Swann Starts Epizyme (EPZM) at Outperform
June 25, 2013 7:50 AM EDTLeerink Swann initiates coverage on Epizyme (NASDAQ: EPZM) with a Outperform. PT $34.00.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
Citi Starts Epizyme (EPZM) at Buy
June 25, 2013 7:12 AM EDTCiti initiates coverage on Epizyme (NASDAQ: EPZM) with a Buy. PT $32.00.
For an analyst ratings summary and ratings history on Epizyme click here. For more ratings news on Epizyme click here.
Shares of Epizyme closed at $27.55 yesterday, with a 52 week range of $18.60-$30.86.... More
